Peter Welford

Stock Analyst at Jefferies

(1.77)
# 2,015
Out of 4,442 analysts
8
Total ratings
100%
Success rate
18.59%
Average return

4 Stocks

AstraZeneca
Jan 3, 2024
Downgrades: Hold
Price Target: n/a
Current: $78.54
Upside: -
GSK
Jan 3, 2024
Upgrades: Buy
Price Target: $39$48
Current: $45.12
Upside: +6.38%
Galapagos NV
Jan 23, 2023
Upgrades: Hold
Price Target: $49$47
Current: $27.27
Upside: +73.08%
Genmab
Sep 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $28.00
Upside: -